Skip to main content

Table 3 Characteristics of newly diagnosed female cancer patients with prior cancer

From: Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study

Index Cancer Site Lung Stomach Colorectum Breast Cervix uteri Corpus uteri
N % N % N % N % N % N %
Total 1681 100 1582 100 1916 100 1588 100 206 100 542 100
Number of prior cancers before the index cancer
 1 1551 92.3 1488 94.1 1794 93.6 1507 94.9 191 92.7 510 94.1
 2 121 7.2 88 5.6 116 6.1 79 5.0 15 7.3 29 5.4
 3 9 0.5 6 0.4 5 0.3 2 0.1 0 0.0 3 0.6
 4 0 0.0 0 0.0 1 0.1 0 0.0 0 0.0 0 0.0
Diagnostic time intervala
  < 3 months 282 16.8 374 23.6 445 23.2 317 20.0 43 20.9 107 19.7
 3 months–1 year 188 11.2 151 9.5 173 9.0 177 11.1 28 13.6 38 7.0
 1–5 years 623 37.1 541 34.2 634 33.1 548 34.5 71 34.5 152 28.0
 5–10 years 373 22.2 324 20.5 421 22.0 357 22.5 40 19.4 156 28.8
 10–15 years 215 12.8 192 12.1 243 12.7 189 11.9 24 11.7 89 16.4
Stage of prior cancerb
 Localized 979 58.2 917 58.0 1155 60.3 882 55.5 105 51.0 300 55.4
 Regional lymph nodes 285 17.0 233 14.7 275 14.4 232 14.6 40 19.4 104 19.2
 Regional extension 185 11.0 174 11.0 202 10.5 212 13.4 15 7.3 66 12.2
 Distant metastasis 66 3.9 100 6.3 117 6.1 112 7.1 13 6.3 20 3.7
 Other or unknown 166 9.9 158 10.0 167 8.7 150 9.4 33 16.0 52 9.6
Treatment of prior cancerb
 Radiotherapy only 24 1.4 32 2.0 37 1.9 28 1.8 3 1.5 10 1.8
 Chemotherapy only 65 3.9 97 6.1 123 6.4 88 5.5 13 6.3 25 4.6
 Chemoradiotherapy 41 2.4 28 1.8 27 1.4 31 2.0 4 1.9 2 0.4
 Surgery only 784 46.6 747 47.2 860 44.9 848 53.4 89 43.2 217 40.0
 Surgery plus chemotherapy or radiotherapy 484 28.8 403 25.5 518 27.0 368 23.2 50 24.3 215 39.7
 Other or unknown 283 16.8 275 17.4 351 18.3 225 14.2 47 22.8 73 13.5
Site of prior cancerb
 Mouth and pharynx 50 3.0 32 2.0 29 1.5 39 2.5 4 1.9 8 1.5
 Esophagus 24 1.4 62 3.9 26 1.4 27 1.7 2 1.0 1 0.2
 Stomach 239 14.2 445 23.2 250 15.7 31 15.0 29 5.4
 Colon 203 12.1 320 20.2 252 15.9 22 10.7 46 8.5
 Rectum 95 5.7 132 8.3 133 8.4 13 6.3 19 3.5
 Liver 48 2.9 104 6.6 93 4.9 58 3.7 9 4.4 3 0.6
 Gallbladder and bile duct 14 0.8 36 2.3 35 1.8 13 0.8 2 1.0 6 1.1
 Pancreas 30 1.8 31 2.0 28 1.5 13 0.8 0 0.0 4 0.7
 Larynx 13 0.8 2 0.1 4 0.2 2 0.1 3 1.5 0 0
 Lung 0 0.0 96 6.1 151 7.9 155 9.8 12 5.8 25 4.6
 Melanoma of skin 1 0.1 3 0.2 3 0.2 3 0.2 0 0.0 1 0.2
 Other skin 27 1.6 42 2.7 39 2.0 30 1.9 3 1.5 12 2.2
 Mesothelioma 1 0.1 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
 Breast 485 28.9 378 23.9 528 27.6 54 26.2 253 46.7
 Cervix uteri 72 4.3 61 3.9 62 3.2 100 6.3 0 0.0 23 4.2
 Corpus uteri 66 3.9 45 2.8 108 5.6 132 8.3 12 5.8 0 0.0
 Uterus 6 0.4 3 0.2 5 0.3 7 0.4 2 1.0 1 0.2
 Ovary 46 2.7 25 1.6 56 2.9 60 3.8 4 1.9 44 8.1
 Bladder 27 1.6 27 1.7 38 2.0 23 1.4 4 1.9 10 1.8
 Renal and urinary tract 49 2.9 26 1.6 67 3.5 51 3.2 7 3.4 12 2.2
 Brain and central nervous system 6 0.4 4 0.3 3 0.2 1 0.1 0 0.0 3 0.6
 Thyroid 86 5.1 40 2.5 68 3.5 131 8.2 1 0.5 17 3.1
 Hodgkin lymphoma 4 0.2 1 0.1 3 0.2 1 0.1 1 0.5 0 0.0
 Non-Hodgkin lymphoma 38 2.3 56 3.5 50 2.6 48 3.0 8 3.9 15 2.8
 Immunoproliferative diseases 0 0.0 0 0.0 1 0.1 1 0.1 0 0.0 0 0.0
 Myeloma 2 0.1 9 0.6 12 0.6 7 0.4 2 1.0 2 0.4
 Lymphoid leukemia 4 0.2 2 0.1 2 0.1 1 0.1 2 1.0 0 0.0
 Myeloid leukemia 4 0.2 7 0.4 8 0.4 9 0.6 1 0.5 2 0.4
 Others 41 2.4 38 2.4 52 2.7 41 2.6 7 3.4 6 1.1
  1. Values are expressed as the number of patients and column percentage
  2. aInterval between the diagnostic dates of the most recent prior cancer and index cancer
  3. bMost recently diagnosed prior cancer